Name: UNITED THERAPEUTICS CORP (UTHR) Stock
Brand: UNITED THERAPEUTICS CORP
Rating: 8 (3 reviews)

UTHR Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Chartmill

United Therapeutics Corp (NASDAQ:UTHR) Offers Affordable Growth with Strong Profitability

4 days ago - By: Chartmill

United Therapeutics Corp (NASDAQ:UTHR) Reports Q3 2025 Earnings: Revenue Misses, EPS Beats Estimates

3 days ago - By: Zacks Investment Research

MKKGY vs. UTHR: Which Stock Is the Better Value Option?

3 days ago - By: The Motley Fool

United Therapeutics (UTHR) Earnings Transcript

3 days ago - By: Investor's Business Daily - Mentions: INSM ARGX LQDA

Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports

4 days ago - By: Zacks Investment Research

Compared to Estimates, United Therapeutics (UTHR) Q3 Earnings: A Look at Key Metrics

4 days ago - By: Investor's Business Daily - Mentions: NVS AAPL

United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short

4 days ago - By: Benzinga - Mentions: CGO ROL ESRT NNBR ...

Earnings Scheduled For October 29, 2025

4 days ago - By: United Therapeutics Corporation

United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results

5 days ago - By: Benzinga

A Peek at United Therapeutics's Future Earnings

10 days ago - By: Zacks Investment Research - Mentions: AMRX

Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for

17 days ago - By: Chartmill

United Therapeutics Corp (NASDAQ:UTHR) Meets Key Peter Lynch Investment Criteria

18 days ago - By: United Therapeutics Corporation

United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025

19 days ago - By: Chartmill

United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Prime Value Investment Candidate

20 days ago - By: United Therapeutics Corporation

United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting

a month ago - By: Zacks Investment Research - Mentions: INSM LQDA

Is IPF the Next Big Market Opportunity for United Therapeutics?

a month ago - By: Zacks Investment Research - Mentions: AMGN

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

a month ago - By: Zacks Investment Research - Mentions: USB APD NEE NI ...

Top Stock Reports for NextEra Energy, U.S. Bancorp and Air Products & Chemicals

a month ago - By: United Therapeutics Corporation

United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis

2 months ago - By: United Therapeutics Corporation

United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum